Publikationen 2023

Added value of randomized biopsy to mpMRI-targeted biopsy of the prostate in a contemporary cohort.
BJU Int 2023;
Chaloupka M, Pyrgidis N, Ebner B, Volz Y, Pfitzinger PL, Berg E, Enzinger B, Atzler M, Ivanova T, Clevert DA, Buchner A, Stief CG, Apfelbeck M

Penile fractures: The price of a Merry Christmas.
BJU Int 2023; 132(6): 651-655;
Pyrgidis N, Chaloupka M, Yolz Y, Pfitzinger P, Apfelbeck M, Weinhold P, Stief C, Marcon J, Schulz GB

Single-fraction prostate-specific membrane antigen positron emission tomography- and multiparametric magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer local recurrences.
BJU Int 2023; 131(1): 101-108;
Ehret F, Hofmann T, Fürweger C, Kufeld M, Staehler M, Muacevic A, Haidenberger A

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.
BJUI Compass 2023; 4(1): 123-129;
Bravi CA, Heidenreich A, Fossati N, Gandaglia G, Suardi N, Mazzone E, Stabile A, Cucchiara V, Osmonov D, Juenemann KP, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat S, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A, Pfister D

Absence of detrusor muscle in TUR-BT specimen - can we predict who is at highest risk?
BMC Urol 2023; 23(1)
Volz Y, Trappmann R, Ebner B, Eismann L, Pyrgidis N, Pfitzinger P, Bischoff R, Schlenker B, Stief C, Schulz GB

Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance-A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting.
Bioengineering (Basel) 2023; 10(2)
Ebner B, Apfelbeck M, Pyrgidis N, Nellessen T, Ledderose S, Pfitzinger PL, Volz Y, Berg E, Enzinger B, Rodler S, Atzler M, Ivanova T, Clevert DA, Stief CG, Chaloupka M

Efficacy and Safety of Platelet-Rich Plasma Injections for the Treatment of Female Sexual Dysfunction and Stress Urinary Incontinence: A Systematic Review.
Biomedicines 2023; 11(11)
Dankova I, Pyrgidis N, Tishukov M, Georgiadou E, Nigdelis MP, Solomayer EF, Marcon J, Stief CG, Hatzichristou D

PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches.
Biomedicines 2023; 11(11)
Bui VN, Unterrainer LM, Brendel M, Kunte SC, Holzgreve A, Allmendinger F, Bartenstein P, Klauschen F, Unterrainer M, Staehler M, Ledderose S

Interstitial Photodynamic Therapy of Glioblastomas: A Long-Term Follow-up Analysis of Survival and Volumetric MRI Data.
Cancers (Basel) 2023; 15(9)
Foglar M, Aumiller M, Bochmann K, Buchner A, El Fahim M, Quach S, Sroka R, Stepp H, Thon N, Forbrig R, Rühm A

Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy.
Cancers (Basel) 2023; 15(12)
Preisser F, Incesu RB, Rajwa P, Chlosta M, Ahmed M, Abreu AL, Cacciamani G, Ribeiro L, Kretschmer A, Westhofen T, Smith JA, Graefen M, Calleris G, Raskin Y, Gontero P, Joniau S, Sanchez-Salas R, Shariat SF, Gill I, Karnes RJ, Cathcart P, Van Der Poel H, Marra G, Tilki D

P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer.
Cancers (Basel) 2023; 15(8)
Ledderose S, Rodler S, Eismann L, Ledderose G, Rudelius M, Junger WG, Ledderose C

Radical Prostatectomy without Prior Biopsy in Patients with High Suspicion of Prostate Cancer Based on Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen Positron Emission Tomography: A Prospective Cohort Study.
Cancers (Basel) 2023; 15(4)
Chaloupka M, Apfelbeck M, Pyrgidis N, Marcon J, Weinhold P, Stief CG

Robot-Assisted Magnetic Resonance Imaging-Targeted versus Systematic Prostate Biopsy; Systematic Review and Meta-Analysis.
Cancers (Basel) 2023; 15(4)
Petov V, Azilgareeva C, Shpikina A, Morozov A, Krupinov G, Kozlov V, Singla N, Gómez Rivas J, Jesús MS, Puliatti S, Checcucci E, Rodler S, Belenchon IR, Kowalewski KF, Veccia A, Mcfarland J, Cacciamani GE, Taratkin M, Enikeev D

Surgical Trends and Complications in Partial and Radical Nephrectomy: Results from the GRAND Study.
Cancers (Basel) 2023; 16(1)
Pyrgidis N, Schulz GB, Stief C, Blajan I, Ivanova T, Graser A, Staehler M

A new era and future of education: the impact of pandemic on online learning - a study from the European School of Urology.
Cent European J Urol 2023; 76(3): 256-262;
Rivas JG, Belenchón IR, Li N, Somani B, Esteban EA, Cacciamani G, Checcucci E, Puliatti S, Taratkin M, Kowalewski KF, Rodler S, Veccia A, Palou J, Liatsikos E

Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal.
Clin Genitourin Cancer 2023;
Staehler M, Rodler S, Brinkmann I, Stief CG, Graser A, Götz M, Herlemann A

mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral center.
Clin Hemorheol Microcirc 2023;
Chaloupka M, Pyrgidis N, Ebner B, Pfitzinger P, Volz Y, Berg E, Abrarova B, Atzler M, Ivanova T, Pfitzinger P, Stief CG, Apfelbeck M, Clevert DA

DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score.
Clin Transl Radiat Oncol 2023; 39
Unger K, Hess J, Link V, Buchner A, Eze C, Li M, Stief C, Kirchner T, Klauschen F, Zitzelsberger H, Niyazi M, Ganswindt U, Schmidt-Hegemann N-S, Belka C

Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy.
Clin Transl Radiat Oncol 2023; 39
Li M, Fan Y, Trapp C, Schmidt-Hegemann NS, Ma J, Buchner A, Lu S, Xu B, Stief C, Wang X, Zhou C, Belka C, Rogowski P

Artificial Intelligence in Surgical Training for Kidney Cancer: A Systematic Review of the Literature.
Diagnostics (Basel) 2023; 13(19)
Rodriguez Peñaranda N, Eissa A, Ferretti S, Bianchi G, Di Bari S, Farinha R, Piazza P, Checcucci E, Belenchón IR, Veccia A, Gomez Rivas J, Taratkin M, Kowalewski KF, Rodler S, De Backer P, Cacciamani GE, De Groote R, Gallagher AG, Mottrie A, Micali S, Puliatti S, YAU Uro-Technology Working Group

Can the Abdominal Aortic Atherosclerotic Plaque Index Predict Functional Outcomes after Robot-Assisted Partial Nephrectomy?
Diagnostics (Basel) 2023; 13(21)
Veccia A, Serafin E, Tafuri A, Malandra S, Maris B, Tomelleri G, Spezia A, Checcucci E, Piazza P, Rodler S, Baekelandt L, Kowalewski KF, Rivero Belenchon I, Taratkin M, Puliatti S, De Backer P, Gomez Rivas J, Cacciamani GE, Zamboni G, Fiorini P, Antonelli A, YAU Uro-Technology Working Group

The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World Setting.
Diagnostics (Basel) 2023; 13(16)
Volz Y, Apfelbeck M, Pyrgidis N, Pfitzinger PL, Berg E, Ebner B, Enzinger B, Ivanova T, Atzler M, Kazmierczak PM, Clevert DA, Stief C, Chaloupka M

Digital Urology.
In R. Huss (Ed.), Digital Medicine: Bringing Digital Solutions to Medical Practice (475-491). Jenny Stanford Publishing, New York, 2023
Buchner A

Operating room team strategies to reduce flow disruptions in high-risk task episodes: resilience in robot-assisted surgery.
Ergonomics 2023; 66(8): 1118-1131
Koch A, Schlenker B, Becker A, Weigl M

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.
Eur J Nucl Med Mol Imaging 2023; 50(8): 2537-2547;
Spohn SKB, Schmidt-Hegemann NS, Ruf J, Mix M, Benndorf M, Bamberg F, Makowski MR, Kirste S, Rühle A, Nouvel J, Sprave T, Vogel MME, Galitsnaya P, Gschwend JE, Gratzke C, Stief C, Löck S, Zwanenburg A, Trapp C, Bernhardt D, Nekolla SG, Li M, Belka C, Combs SE, Eiber M, Unterrainer L, Unterrainer M, Bartenstein P, Grosu AL, Zamboglou C, Peeken JC

Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.
Eur J Nucl Med Mol Imaging 2023; 50(12): 3750-3754;
Holzgreve A, Unterrainer M, Calais J, Adams T, Oprea-Lager DE, Goffin K, Lopci E, Unterrainer LM, Kramer KKM, Schmidt-Hegemann NS, Casuscelli J, Stief CG, Ricke J, Bartenstein P, Kunz WG, Mehrens D

Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer.
Eur Urol 2023;
Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR

Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients.
Eur Radiol 2023;
Grawe F, Blom F, Winkelmann M, Burgard C, Schmid-Tannwald C, Unterrainer LM, Sheikh GT, Pfitzinger PL, Kazmierczak P, Cyran CC, Ricke J, Stief CG, Bartenstein P, Ruebenthaler J, Fabritius MP, Geyer T

Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology.
Eur Urol 2023;
Eppler M, Ganjavi C, Ramacciotti LS, Piazza P, Rodler S, Checcucci E, Gomez Rivas J, Kowalewski KF, Belenchón IR, Puliatti S, Taratkin M, Veccia A, Baekelandt L, Teoh JY, Somani BK, Wroclawski M, Abreu A, Porpiglia F, Gill IS, Murphy DG, Canes D, Cacciamani GE

Patients' Trust in Artificial Intelligence-based Decision-making for Localized Prostate Cancer: Results from a Prospective Trial.
Eur Urol Focus 2023;
Rodler S, Kopliku R, Ulrich D, Kaltenhauser A, Casuscelli J, Eismann L, Waidelich R, Buchner A, Butz A, Cacciamani GE, Stief CG, Westhofen T

Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis.
Eur Urol Focus 2023; 9(6): 920-929;
Katsimperis S, Tzelves L, Tandogdu Z, Ta A, Geraghty R, Bellos T, Manolitsis I, Pyrgidis N, Schulz GB, Sridhar A, Shaw G, Kelly J, Skolarikos A

Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis.
Eur Urol Focus 2023; 9(5): 788-798;
Schallenberg S, Dragomir MP, Anders P, Ebner B, Volz Y, Eismann L, Rodler S, Casuscelli J, Buchner A, Klauschen F, Stief C, Horst D, Schulz GB

Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.
Eur Urol Focus 2023; 9(4): 621-628;
Zattoni F, Marra G, Martini A, Kasivisvanathan V, Grummet J, Harkin T, Ploussard G, Olivier J, Chiu PK, Valerio M, Marquis A, Gontero P, Guo H, Zhuang J, Frydenberg M, Moon D, Morlacco A, Kretschmer A, Barletta F, Heidegger I, Tilki D, van den Bergh R, Dal Moro F, Briganti A, Montorsi F, Novara G, Gandaglia G, EAU-YAU Prostate Cancer Working Party

Radiomics Signature Using Manual Versus Automated Segmentation for Lymph Node Staging of Bladder Cancer.
Eur Urol Focus 2023; 9(1): 145-153
Gresser E, Woznicki P, Messmer K, Schreier A, Kunz WG, Ingrisch M, Stief C, Ricke J, Nörenberg D, Buchner A, Schulz GB

Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort.
Eur Urol Focus 2023; 9(4): 645-649
Calleris G, Marra G, Benfant N, Rajwa P, Ahmed M, Abreu A, Cacciamani G, Ghoreifi A, Ribeiro L, Westhofen T, Tourinho-Barbosa R, Raskin Y, Veerman H, Albisinni S, Smith JA, Rouprêt M, Oderda M, Massari E, Persad R, Van Der Poel H, Joniau S, Sanchez-Salas R, Kretschmer A, Cathcart P, Gill I, Karnes RJ, Tilki D, Shariat SF, Touijer K, Gontero P

The Impact of Telemedicine in Reducing the Carbon Footprint in Health Care: A Systematic Review and Cumulative Analysis of 68 Million Clinical Consultations.
Eur Urol Focus 2023; 9(6): 873-887;
Rodler S, Ramacciotti LS, Maas M, Mokhtar D, Hershenhouse J, De Castro Abreu AL, Fuchs G, Stief CG, Gill IS, Cacciamani GE

The Long but Necessary Journey Towards Optimization of the Cause-Effect Relationship Between Input and Output for Accountable Use of ChatGPT for Academic Purposes.
Eur Urol Focus 2023; 9(6): 1065-1067;
Piazza P, Checcucci E, Puliatti S, Belenchòn IR, Veccia A, Rivas JG, Taratkin M, Kowalewski KF, Rodler S, Cacciamani GE, Uro-Technology, Social Media Working Group of the Young Academic Urologists Working Party of the European Association of Urology

Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.
Eur Urol Oncol 2023;
Rajwa P, Robesti D, Chaloupka M, Zattoni F, Giesen A, Huebner NA, Krzywon A, Miszczyk M, Moll M, Stando R, Cisero E, Semko S, Checcucci E, Devos G, Apfelbeck M, Gatti C, Marra G, van den Bergh RCN, Goldner G, Rasul S, Ceci F, Dal Moro F, Porpiglia F, Gontero P, Bjartell A, Stief C, Heidenreich A, Joniau S, Briganti A, Shariat SF, Gandaglia G, EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party

Digital Therapeutics in Urology: An Innovative Approach to Patient Care and Management.
Eur Urol Open Sci 2023; 55(): 23-27
Rodler S, Kowalewski KF, Scheibert H, Bensel M, Stadelmeier LF, Styn A, Belenchon IR, Taratkin M, Puliatti S, Gomez Rivas J, Veccia A, Piazza P, Checcucci E, Michel MS, Stief CG, Cacciamani G, Young Academic Urologists Urotechnology Group of the European Association of Urology

Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab.
Front Immunol 2023; Aug 9;14:1186388
Lyu C, Stadlbauer B, Wang L, Buchner A, Pohla H

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
Front Med (Lausanne) 2023; 9
Sauerbruch T, Hennenberg M, Trebicka J, Schierwagen R

Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003.
Front Pharmacol 2023; 14
Liu Y, Wang R, Huang R, Rutz B, Ciotkowska A, Tamalunas A, Hu S, Trieb M, Waidelich R, Strittmatter F, Stief CG, Hennenberg M

Diagnosis and Therapy of Female Urinary Incontinence. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/091, January 2022): Part 1 with Recommendations on Diagnostics and Conservative and Medical Treatment.
Geburtsh Frauenheilk 2023; 83(4): 377-409
Naumann G, Aigmueller T, Bader W, Bauer R, Beilecke K, Meier CB, Bruer G, Bschleipfer T, Deniz M, Fink T, Gabriel B, Graeble R, Grothoff M, Haverkamp A, Hampel C, Henscher U, Huebner M, Huemer H, Kociszewski J, Koelbl H, Koelle D, Kropshofer S, Kuhn A, Nothacker M, Oelke M, Peschers U, Preyer O, Schultz-Lampel D, Tamussino K, Tholen R, Tunn R, Viereck V, Reisenauer C

Diagnosis and Therapy of Female Urinary Incontinence. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/091, January 2022): Part 2 with Recommendations on Interventional/Surgical Therapy of Overactive Bladder, Surgical Treatment of Stress Urinary Incontinence and Diagnosis and Therapy of Iatrogenic Urogenital Fistula.
Geburtsh Frauenheilk 2023; 83(4): 410-436
Naumann G, Aigmueller T, Bader W, Bauer R, Beilecke K, Meier CB, Bruer G, Bschleipfer T, Deniz M, Fink T, Gabriel B, Graeble R, Grothoff M, Haverkamp A, Hampel C, Henscher U, Huebner M, Huemer H, Kociszewski J, Koelbl H, Koelle D, Kropshofer S, Kuhn A, Nothacker M, Oelke M, Peschers U, Preyer O, Schultz-Lampel D, Tamussino K, Tholen R, Tunn R, Viereck V, Reisenauer C

Adrenoceptors in the Lower Urinary Tract.
Handb Exp Pharmacol 2023;
Hennenberg M, Michel MC

The Impact on Urology Residents' Learning of Social Media and Web Technologies after the Pandemic: A Step Forward through the Sharing of Knowledge.
Healthcare (Basel) 2023; 11(13)
Rodler S, Bujoreanu CE, Baekelandt L, Volpi G, Puliatti S, Kowalewski KF, Belenchon IR, Taratkin M, Rivas JG, Veccia A, Piazza P, Carrion DM, Cacciamani GE, Esperto F, Checcucci E

Perioperative outcomes of penile prosthesis implantation in Germany: results from the GRAND study.
Int J Impot Res 2023;
Pyrgidis N, Schulz GB, Chaloupka M, Volz Y, Pfitzinger PL, Rodler S, Berg E, Weinhold P, Jokisch F, Stief CG, Becker AJ, Marcon J

The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?
Int J Radiat Oncol Biol Phys 2023; 117(5)
Siva S, Staehler M

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board.
J Cancer Res Clin Oncol 2023; 149(5): 1905-1915;
Heinrich K, Miller-Phillips L, Ziemann F, Hasselmann K, Rühlmann K, Flach M, Biro D, von Bergwelt-Baildon M, Holch J, Herold T, von Baumgarten L, Greif PA, Jeremias I, Wuerstlein R, Casuscelli J, Spitzweg C, Seidensticker M, Renz B, Corradini S, Baumeister P, Goni E, Tufman A, Jung A, Kumbrink J, Kirchner T, Klauschen F, Metzeler KH, Heinemann V, Westphalen CB

Is the Standard Artificial Urinary Sphincter AMS 800 Still a Treatment Option for the Irradiated Male Patient Presenting with a Devastated Bladder Outlet?
J Clin Med 2023; 12(12): 4002
Queissert F, Huesch T, Kretschmer A, Kirschner-Hermanns R, Pottek T, Olianas R, Friedl A, Homberg R, Pfitzenmaier J, Naumann CM, Nyarangi-Dix J, Hofmann T, Rose A, Weidemann C, Wotzka C, Hübner W, Loertzer H, Abdunnur R, Grabbert M, Anding R, Bauer RM, Haferkamp A, Schrader AJ, Debates on Male Incontinence (DOMINO)-Project

Prospects of Endovenous Laser Ablation (EVLA) Standardization-Mid-Term Results of a Four-Zone Dosimetry Guiding Tool for 1940 nm Laser.
J Clin Med 2023; 12(13): 4313
Setia A, Dikic S, Demhasaj S, Schmitz-Rixen T, Sroka R, Schmedt CG

A Systematic Review of New Imaging Technologies for Robotic Prostatectomy: From Molecular Imaging to Augmented Reality.
J Clin Med 2023; 12(16): 5425
Rodler S, Kidess MA, Westhofen T, Kowalewski KF, Belenchon IR, Taratkin M, Puliatti S, Gómez Rivas J, Veccia A, Piazza P, Checcucci E, Stief CG, Cacciamani GE

The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study.
J Clin Med 2023; 12(21): 6749
Strobach D, Haimerl L, Mannell H, Stief CG, Karl A, Grimm T, Buchner A

Perioperative outcomes of same-session bilateral versus unilateral ureteroscopy for stone removal: Results from the GRAND study.
J Endourol 2023;
Pyrgidis N, Chaloupka M, Ebner B, Stief C, Weinhold P, Marcon J, Schulz GB

Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.
J Natl Compr Canc Netw 2023; 21(1): 43-50.e2;
Mehrens D, Kramer KKM, Unterrainer LM, Beyer L, Bartenstein P, Froelich MF, Tollens F, Ricke J, Rübenthaler J, Schmidt-Hegemann NS, Herlemann A, Unterrainer M, Kunz WG

Interstitial photodynamic therapy for newly diagnosed glioblastoma.
J Neurooncol 2023; 162(1): 217-223;
Quach S, Schwartz C, Aumiller M, Foglar M, Schmutzer M, Katzendobler S, El Fahim M, Forbrig R, Bochmann K, Egensperger R, Sroka R, Stepp H, Rühm A, Thon N

An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients.
J Nucl Med 2023; 64(6): 918-923;
Trapp C, Oliinyk D, Rogowski P, Von Bestenbostel R, Ganswindt U, Li M, Eze C, Bartenstein P, Beyer L, Ilhan H, Sheikh G, Unterrainer L, Stief C, Westhofen T, Kunz WG, Unterrainer M, Belka C, Schmidt-Hegemann NS

Delayed placement of an inflatable penile prosthesis is associated with a high complication rate in men with a history of ischemic priapism.
J Sex Med 2023; 20(7): 1052-1056
Barham DW, Chang C, Hammad M, Pyrgidis N, Swerdloff D, Gross K, Hatzichristodoulou G, Hsieh TC, Hotaling JM, Jenkins LC, Jones JM, Modgil V, Osmonov D, Pearce I, Perito P, Sadeghi-Nejad H, Suarez-Sarmiento A, Sempels M, Service CA, Simhan J, Yafi FA, Gross MS, PUMP (Prosthetic Urology Multi-institutional Partnership) collaborators

AUA-Recommended Antibiotic Prophylaxis for Primary Penile Implantation Results in a Higher, Not Lower, Risk for Postoperative Infection: A Multicenter Analysis. Reply.
J Urol 2023; 209(3): 511-512
Barham DW, Pyrgidis N, Gross MS, Simhan J, Yafi FA

Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Letter.
J Urol 2023; 210(5): 733-734
Kalyvianakis D, Poulios E, Mykoniatis I, Pyrgidis N, Zilotis F, Hatzichristou D

Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy.
J Urol 2023; 210(2): 273-279;
Reese SW, Khaleel S, Silagy A, Xie A, Eismann L, Vazquez-Rivera K, Oparanozie A, Patil S, Coleman J, Motzer R, Kotecha RR, Russo P, Voss MH, Hakimi AA

Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma.
J Urol 2023; 210(1): 117-127;
Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, Checcucci E, Amparore D, Haiquel L, Rodriguez-Sanchez L, Ploussard G, Qiang P, Affentranger A, Marquis A, Marra G, Ettala O, Zattoni F, Falagario UG, De Angelis M, Kesch C, Apfelbeck M, Al-Hammouri T, Kretschmer A, Kasivisvanathan V, Preisser F, Lefebvre E, Olivier J, Radtke JP, Briganti A, Montorsi F, Carrieri G, Moro FD, Boström P, Jambor I, Gontero P, Chiu PK, John H, Macek P, Porpiglia F, Hermanns T, van den Bergh RCN, van Basten JA, Gandaglia G, Valerio M

Female Sexual Dysfunction in Heart Failure: A Prevalence Meta-Analysis.
JACC Heart Fail 2023; 11(9): 1281-1283
Tishukov M, Farmakis IT, Sokolakis I, Pyrgidis N

Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.
Lancet 2023; 401(10379): 821-832; 
Motzer RJ, Russo P, Grünwald V, Tomita Y, Zurawski B, Parikh O, Buti S, Barthélémy P, Goh JC, Ye D, Lingua A, Lattouf JB, Albigès L, George S, Shuch B, Sosman J, Staehler M, Vázquez Estévez S, Simsek B, Spiridigliozzi J, Chudnovsky A, Bex A

Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Lancet Oncol 2023; 24(3): 228-238;
Choueiri TK, Eto M, Motzer R, De Giorgi U, Buchler T, Basappa NS, Méndez-Vidal MJ, Tjulandin S, Hoon Park S, Melichar B, Hutson T, Alemany C, McGregor B, Powles T, Grünwald V, Alekseev B, Rha SY, Kopyltsov E, Kapoor A, Alonso Gordoa T, Goh JC, Staehler M, Merchan JR, Xie R, Perini RF, Mody K, McKenzie J, Porta CG

Silencing of CDC42 inhibits contraction and growth-related functions in prostate stromal cells, which is mimicked by ML141.
Life Sci 2023; 329()
Wang R, Huang R, Liu Y, Tamalunas A, Stief CG, Hennenberg M

[Early detection of prostate cancer].
MMW Fortschr Med 2023; 165(8): 50-52;
Rodler S, Stief CG

[Etiology, diagnostic pathway and treatment of urethral strictures in men].
MMW Fortschr Med 2023; 165(18): 66-69;
Berg EK, Chaloupka M, Götz M, Hoffmann M, Askari-Motlagh D, Stief CG, Bischoff R

[Imaging in renal cell carcinoma].
MMW Fortschr Med 2023; 165(13): 32-34
Pfitzinger PL, Kazmierczak P, Clevert DA, Marcon J

[Localized therapy of renal cell carcinoma].
MMW Fortschr Med 2023; 165(13): 34-38; 
Brinkmann I, Stief CG, Marcon J

[Editorial].
MMW Fortschr Med 2023; 165(13): 
Stief CG

[Systemic treatment of renal cancer and management of immunotherapy related toxicity].
MMW Fortschr Med 2023; 165(13): 39-41; 
Berg EK, Aydogdu C, Götz M, Rodler S, Tamalunas A, Stief CG, Casuscelli J

[Urinary tract infections in children].
MMW Fortschr Med 2023; 165(7): 58-59;
Stredele R, Atzler M, Becker KM, Zeller C, Lisec K, Kammer B, Stief CG, Heinrich MB

Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle.
Naunyn Schmiedebergs Arch Pharmacol 2023;
Hu S, Trieb M, Huang R, Tamalunas A, Keller P, Götz M, Waidelich R, Stief CG, Hennenberg M

Selective inhibition of neurogenic, but not agonist-induced contractions by phospholipase A2 inhibitors points to presynaptic phospholipase A2 functions in contractile neurotransmission to human prostate smooth muscle.
Neurourol Urodyn 2023; 42(7): 1522-1531
Hu S, Huang R, Keller P, Götz M, Tamalunas A, Weinhold P, Waidelich R, Stief CG, Hennenberg M

Quantitative differentiation of minimal-fat angiomyolipomas from renal cell carcinomas using grating-based x-ray phase-contrast computed tomography: An ex vivo study.
PLoS ONE 2023; 18(4)
Birnbacher L, Braunagel M, Willner M, Marschner M, De Marco F, Viermetz M, Auweter S, Notohamiprodjo S, Hellbach K, Notohamiprodjo M, Staehler M, Pfeiffer D, Reiser MF, Pfeiffer F, Herzen J

The impact of previous inguinal mesh hernioplasty on oncological and patient-reported outcomes following radical prostatectomy.
Prostate 2023; 83(14):1313-1322;
Westhofen T, Bensel M, Schlenker B, Becker A, Stief CG, Kretschmer A, Buchner A

A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading.
Prostate Cancer Prostatic Dis 2023; 26(4): 681-692;
Morozov A, Taratkin M, Bazarkin A, Rivas JG, Puliatti S, Checcucci E, Belenchon IR, Kowalewski KF, Shpikina A, Singla N, Teoh JYC, Kozlov V, Rodler S, Piazza P, Fajkovic H, Yakimov M, Abreu AL, Cacciamani GE, Enikeev D, Young Academic Urologists (YAU) Working Group in Uro-technology of the European Association of Urology

Enucleation of the prostate as retreatment for recurrent or residual benign prostatic obstruction: a systematic review and a meta-analysis.
Prostate Cancer Prostatic Dis 2023; 26(4): 693-701;
Pyrgidis N, Mykoniatis I, Lusuardi L, Schulz GB, Sokolakis I, Stief C, Sountoulides P

Impact of persistent PSA after salvage radical prostatectomy: a multicenter study.
Prostate Cancer Prostatic Dis 2023;
Preisser F, Incesu RB, Rajwa P, Chlosta M, Nohe F, Ahmed M, Abreu AL, Cacciamani G, Ribeiro L, Kretschmer A, Westhofen T, Smith JA, Steuber T, Calleris G, Raskin Y, Gontero P, Joniau S, Sanchez-Salas R, Shariat SF, Gill I, Karnes RJ, Cathcart P, Van Der Poel H, Marra G, Tilki D

Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study.
Radiother Oncol 2023;
Scharl S, Zamboglou C, Strouthos I, Farolfi A, Serani F, Lanzafame H, Giuseppe Morganti A, Trapp C, Koerber SA, Debus J, Peeken JC, Vogel MME, Vrachimis A, K B Spohn S, Ruf J, Grosu AL, Ceci F, Fendler WP, Bartenstein P, Kroeze SGC, Guckenberger M, Krafcsik M, Klopscheck C, Fanti S, Hruby G, Emmett L, Belka C, Stief C, Schmidt-Hegemann NS, Henkenberens C, Mayer B, Miksch J, Shelan M, Aebersold DM, Thamm R, Wiegel T

Explainable ML models for a deeper insight on treatment decision for localized prostate cancer.
Sci Rep 2023; 13(1)
Han JH, Lee S, Lee B, Baek OK, Washington SL, Herlemann A, Lonergan PE, Carroll PR, Jeong CW, Cooperberg MR

Platelet-rich plasma for the treatment of erectile dysfunction: a systematic review of preclinical and clinical studies.
Sex Med Rev 2023; 11(4): 359-368
Poulios E, Mykoniatis I, Pyrgidis N, Kalyvianakis D, Hatzichristou D

Standard operating procedure to reveal prostate cancer specific volatile organic molecules by infrared spectroscopy.
Spectrochim Acta A Mol Biomol Spectrosc 2023; 304()
Maiti KS, Fill E, Strittmatter F, Volz Y, Sroka R, Apolonski A

Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial.
Strahlenther Onkol 2023; 199(6): 565-573;
Krug D, Imhoff D, Haidenberger A, Heßler N, Schäfer J, Huttenlocher S, Chatzikonstantinou G, Fürweger C, Ramm U, König IR, Chun F, Staehler M, Rödel C, Muacevic A, Vonthein R, Dunst J, Blanck O

Associations of flow disruptions with patient, staff, and process outcomes: a prospective observational study of robotic-assisted radical prostatectomies.
Surg Endosc 2023; 37(9): 6964-6974
Koch A, Quartucci C, Buchner A, Schlenker B, Becker A, Catchpole K, Weigl M

Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial.
Target Oncol 2023; 18(5): 639-641;
Motzer RJ, Russo P, Grünwald V, Tomita Y, Zurawski B, Parikh O, Buti S, Barthélémy P, Goh JC, Ye D, Lingua A, Lattouf JB, Albigès L, George S, Shuch B, Sosman J, Staehler M, Vázquez Estévez S, Simsek B, Spiridigliozzi J, Chudnovsky A, Bex A

[Benign Prostate Hyperplasia - Current Medical Therapy, New Developments, and Side Effects].
Ther Umsch 2023; 80(3): 113-122;
Tamalunas A, Keller P, Schott M, Atzler M, Ebner B, Hennenberg M, Stief CG, Magistro G

[Laser Techniques in the Treatment of Benign Prostatic Syndrome].
Ther Umsch 2023; 80(3): 141-146;
Brinkmann I, Schott M, Keller P, Tamalunas A, Atzler M, Ebner B, Stief CG, Magistro G

Oncological impact of perioperative blood transfusion in bladder cancer patients undergoing radical cystectomy: Do we need to consider storage time of blood units, donor age, or gender matching?
Transfusion 2023;
Ebner B, Fleckenstein F, Volz Y, Eismann L, Hermans J, Buchner A, Enzinger B, Weinhold P, Wichmann C, Stief CG, Humpe A, Pyrgidis N, Schulz GB

Non-Invasive Zinc Protoporphyrin Screening Offers Opportunities for Secondary Prevention of Iron Deficiency in Blood Donors.
Transfus Med Hemother 2023; 50(4): 303-312;
Schliemann A, Homann C, Hennig G, Lang A, Holdt LM, Vogeser M, Sroka R, Stepp H, Weinauer F, Quenzel EM

Is cortisol an endogenous mediator of erectile dysfunction in the adult male?
Transl Androl Urol 2023; 12(5): 684-689
Rahardjo HE, Becker AJ, Märker V, Kuczyk MA, Ückert S

Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
Urol Int 2023; 107(1): 72-79;
Eismann L, Bohn L, Buchner A, Casuscelli J, Volz Y, Weinhold P, Wülfing C, Waidelich R, Stief CG, Schlenker B, Rodler S

Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma.
Urol Int 2023; (): 1-10;
Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Duensing S, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos F, Walter B, Otto W, Burger M, Erlmeier M, Schrader AJ, Hartmann A, Erlmeier F, Steffens S, German Network Of Kidney Cancer

Upstaging after TUR-BT for non-muscle invasive cancer of the bladder - Who is at highest risk?
Urol Int 2023;
Volz Y, Trappmann R, Ebner B, Eismann L, Enzinger B, Hermanns J, Pyrgidis N, Stief C, Schulz GB

Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence.
Urol Oncol 2023; 41(7): 325.e1-325.e8;
Eismann L, von Walter P, Jung A, Chaloupka M, Rodler S, Westhofen T, Buchner A, Stief CG, Stadler T, Schlenker B

[Common errors, pitfalls, and management of complications of prostate biopsy : The most common diagnostic and procedural challenges of transrectal fusion prostate biopsy in the initial diagnosis of clinically significant prostate cancer].
Urologie 2023; 62(5): 479-486;
Enzinger B, Pfitzinger PL, Ebner B, Ivanova T, Volz Y, Apfelbeck M, Kazmierczak P, Stief C, Chaloupka M

[Current state of prostate biopsy].
Urologie 2023; 62(5): 447-448;
Stief CG

[Digitalization in urology-challenge and opportunity].
Urologie 2023; 62(9): 913-928;
AK Informationstechnologie und Dokumentation (IT@DOC) (DGU), AK Versorgungsforschung, Qualität und Ökonomie (DGU) , AK Informationstechnologie und Dokumentation (IT@DOC) (DGU) , AK Versorgungsforschung, Qualität und Ökonomie (DGU) , AK Bildgebende Systeme (DGU), Sektion Urologie (DEGUM) , Witzsch UKF, Borkowetz A, Enzmann T, Rodler S, Leyh-Bannurah SR, Loch T, Borgmann H, Steidle O

[Factors influencing job satisfaction of female urologists-results of a survey by the German Society of Urology (DGU)].
Urologie 2023; 62(12): 1302-1308
Siech C, Knipper S, Bellut L, Herlemann A, Müller K, Pompe R, Walach TM, Wiemer L, Welte MN, Weinberger S, Greiser EM, Schönburg S

[Semper fidelis].
Urologie 2023; 62(2): 123-124
Bauer RM, Hampel C

[Transrectal vs. transperineal fusion biopsy of the prostate : Time to switch to the perineal technique-comparison of methods and description of the transperineal procedure under local anesthesia].
Urologie 2023; 62(5): 473-478;
Pfitzinger PL, Enzinger B, Ebner B, Ivanova T, Volz Y, Chaloupka M, Apfelbeck M, Stief C

Efficacy, Efficiency, and Safety of En-bloc vs. Three-lobe Enucleation of the Prostate: A Propensity Score-Matched Analysis.
Urology 2023; 175(): 48-55;
Tamalunas A, Schott M, Keller P, Atzler M, Ebner B, Hennenberg M, Stief CG, Magistro G

The impact of laser energy on functional outcome following Holmium Laser Enucleation of the prostate.
Urology 2023; 182(): 190-195;
Westhofen T, Buchner A, Eismann L, Rodler S, Keller P, Atzler M, Jokisch F, Waidelich R, Stief ABCG, Weinhold P

Characterization of Human Papilloma Virus in Prostate Cancer Patients Undergoing Radical Prostatectomy-A Prospective Study of 140 Patients.
Viruses 2023; 15(6)
Nellessen T, Ebner B, Pyrgidis N, Ledderose S, Kretschmer A, Marcon J, Teupser D, Mayr D, Faihs V, Stief CG, French LE, Herlemann A, Reinholz M

Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States.
World J Mens Health 2023; 41(4): 940-950;
Han JH, Herlemann A, Washington SL, Lonergan PE, Carroll PR, Cooperberg MR, Jeong CW

Assessment of single-probe dual-energy lithotripters in percutaneous nephrolithotomy: a systematic review and meta-analysis of preclinical and clinical studies.
World J Urol 2023; 41(2): 551-565;
Mykoniatis I, Pyrgidis N, Tzelves L, Pietropaolo A, Juliebø-Jones P, De Coninck V, Hameed BMZ, Chaloupka M, Schulz GB, Stief C, Kallidonis P, Somani BK, Skolarikos A

Current perceptions and working time models of female urologists in Germany: results of a large-scale survey.
World J Urol 2023; 41(11): 3161-3168
Weinberger S, Welte MN, Knipper S, Siech C, Greiser EM, Wiemer L, Müller K, Bellut L, Herlemann A, Schoenburg S, Walach MT

The Rho-kinase inhibitor Y27632 promotes ureteral relaxation in an in vivo rat model for partial ureteral obstruction.
World J Urol 2023; 41(9): 2541-2547
Villa L, Weinhold P, Zaffuto E, Castiglione F, Pozzi E, Ventimiglia E, Buono R, Briganti A, Montorsi F, Salonia A, Hedlund P